121 related articles for article (PubMed ID: 6975443)
1. [Evaluation of C3d in primitive chronic glomerular nephritis (author's transl)].
Lagrue G; Branellec A; Intrator L; Moisy M; Sobel A
Nephrologie; 1980; 1(1):20-2. PubMed ID: 6975443
[TBL] [Abstract][Full Text] [Related]
2. [Measurements of serum C3d in primitive chronic glomerular nephropathies (author's transl)].
Lagrue G; Branellec A; Intrator L; Moisy M; Sobel A
Nouv Presse Med; 1979 Mar; 8(14):1153-6. PubMed ID: 461145
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical significance of circulating immune complexes in glomerulonephritis.
Valentijn RM; Daha MR; Van Es LA
Neth J Med; 1984; 27(9):340-9. PubMed ID: 6392910
[No Abstract] [Full Text] [Related]
4. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
[TBL] [Abstract][Full Text] [Related]
5. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
Bartelik S
Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
[TBL] [Abstract][Full Text] [Related]
6. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
Berthoux FC; Freyria AM
Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
[TBL] [Abstract][Full Text] [Related]
7. Significance of complement (C3) in lipoid nephrosis and glomerulonephritis.
Mehta KP; Baxi AJ; Kulkarni SK; Merchant SM; Babar ST
Indian Pediatr; 1978 Oct; 15(10):813-8. PubMed ID: 730303
[No Abstract] [Full Text] [Related]
8. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
9. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
[TBL] [Abstract][Full Text] [Related]
10. [Complement fragment C 3d in the plasma of patients with chronic polyarthritis].
Stannat S; Peter HH; Raspe HH; Deicher H
Z Rheumatol; 1986; 45(2):47-51. PubMed ID: 3487899
[TBL] [Abstract][Full Text] [Related]
11. C4 nephritic factor in a patient with chronic glomerulonephritis.
Fujita T; Sumita T; Yoshida S; Ito S; Tamura N
J Clin Lab Immunol; 1987 Feb; 22(2):65-70. PubMed ID: 3298656
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels and glomerular deposits of some components of complement in glomerular diseases. Correlations in 172 cases].
Rovati C; Barbiano di Belgiojoso G; Durante A; Minetti L
Minerva Nefrol; 1975; 22(6):252-61. PubMed ID: 1223702
[No Abstract] [Full Text] [Related]
13. Recent immunologic data on human glomerulonephritis.
Lesavre P; Monteiro RC; Chevailler A; Berger J; Halbwachs-Mecarelli L; Noël LH
Adv Nephrol Necker Hosp; 1988; 17():57-75. PubMed ID: 3124552
[No Abstract] [Full Text] [Related]
14. Complement activation in bronchial asthma evaluated by the C3d/C3 index.
Michel O; Sergysels R; Duchateau J
Ann Allergy; 1986 Dec; 57(6):405-8. PubMed ID: 3491553
[TBL] [Abstract][Full Text] [Related]
15. [Immunological studies of glomerulonephritis].
Belovezhdov N; Altŭnkova I
Vutr Boles; 1981; 20(4):38-46. PubMed ID: 7303639
[TBL] [Abstract][Full Text] [Related]
16. Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis.
Muso E; Sekita K; Doi T; Kuwahara T; Yoshida H; Tamura T; Kawai C; Hamashima Y
Clin Immunol Immunopathol; 1984 Sep; 32(3):351-8. PubMed ID: 6380844
[TBL] [Abstract][Full Text] [Related]
17. [Immune complexes and complement in leprosy (author's transl)].
Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in glomerulonephritis.
Baer D
N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
[No Abstract] [Full Text] [Related]
20. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
